Clinical Trial Update: A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II study evaluating the safety and immunogenicity of the ChAdOx2 RabG rabies vaccine candidate; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• ChAdOx2 RabG

Snippet

Sponsor: University of Oxford | Conditions: Rabies | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING